市場調査レポート
商品コード
1072846
ラボ用ろ過の市場規模・シェア・動向分析:製品・技術・エンドユーザー・地域別の展望・競合戦略・各種区分別の予測 (~2030年)Laboratory Filtration Market Size, Share & Trends Analysis By Product, By Technique, By End-Users, By, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030 |
ラボ用ろ過の市場規模・シェア・動向分析:製品・技術・エンドユーザー・地域別の展望・競合戦略・各種区分別の予測 (~2030年) |
出版日: 2022年04月27日
発行: SPER Market Research Pvt. Ltd.
ページ情報: 英文 240 Pages
納期: 即日から翌営業日
|
世界のラボ用ろ過の市場規模は予測期間中7.4%のCAGRで推移し、2030年には68億4,000万米ドルの規模に成長すると予測されています。
製薬・バイオ医薬品業界によるR&D投資の増加、膜ろ過技術に対する需要の高まり、エンドユーザー部門における純度ニーズの高まり、バイオ医薬品の高分子開発への注力などの要因が同市場の成長を推進しています。一方で、ラボ用ろ過装置は高コストで競争が激しく、利益率が低いため、R&Dへの投資が進まないといった課題があります。
当レポートでは、世界のラボ用ろ過の市場を調査し、市場概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、主要企業のプロファイルなどをまとめています。
Global Laboratory Filtration Market is projected to be worth USD 6.84 billion by 2030.
According to SPER Market Research, the Laboratory Filtration Market is estimated to reach USD 6.84 billion by 2030 with a CAGR of 7.4%. Increasing investment in research & development by the pharmaceutical & biopharmaceutical industry, rising demand for membrane filtration technology, growing purity needs in end-user segments, increasing focus on developing large-molecule in biopharmaceuticals; are the key factors for the escalation of this market.
The outbreak of COVID-19 pandemic globally led to increase in the manufacturing of vaccine, this in turn adopted the laboratory filtration techniques for research & development of vaccines.
Segments covered By Product, By Technique, By End-Users, By Region.
Geographies covered: North America, Europe, Asia Pacific, Latin America, Middle East, Africa
Companies Covered: 3M Company, Agilent Technologies, Inc, Ahlstrom-Munksjo, AMD Manufacturing, Inc., AQUAPORIN A/S, Avantor, Inc, Cole-Parmer, Danaher Corporation, Filtros Anoia, GEA, GROUP AKTIENGESELLSCHAFT, Hawach Scientific, Koch Separation Solutions, MACHEREY-NAGEL GmbH & Co. KG, MANN+HUMMEL, Membracon, Merck Millipore, NS Filtration ApS, Prosperity Biotech (Shandong) Co., Ltd., S.p.A, Sartorius AG, STERIS, Sterlitech Corporation, Synder Filtration, Thermo Fisher Scientific, Veolia Water Technologies
Laboratory filtration products used by Pharmaceutical and biotechnology companies for production of novel drugs. Biotechnology based drugs significance is projected to rise. The giant pharmaceutical companies are escalating their investments in research & development.
The pharmaceutical & biotechnology industry are the end users of laboratory filtration equipment. High cost and competition in the laboratory filtration markets holding back the producer to invest in research & development due to very less profit margin.
Nano-fiber coating technology gives greater elasticity, control, and resilience than the conventional process of electro spinning. Advanced microfiltration, Reverse osmosis and ultra filtration, liquid filtration use this technique.
Based on the Product, Laboratory Filtration Market is segmented as; Filtration Media (Capsule Filters, Filter Papers, Filtration Microplates, Membrane Filters, Syringe Filters, Syringeless Filters), Filtration Assemblies (Microfiltration Assemblies, Reverse Osmosis Assemblies, Ultrafiltration Assemblies, Vacuum Filtration Assemblies).
Filtration Accessories (Cartridges, Dispensers, Filter Flasks, Filter Funnels, Filter Holders, Filter Housings, Seals, Vacuum Pumps).
Based on the Technique, Laboratory Filtration Market is segmented as; Microfiltration, Nanofiltration, Reverse Osmosis, Ultra filtration, Vacuum Filtration.
Based on the End-Users, Laboratory Filtration Market is segmented as; Academic & Research Institutions, Food & Beverage Industry, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies.
North America dominates the prime share of this market; this is due the concentration of giant food & beverage, pharmaceuticals, bio pharmaceutical and health care industries.